Hepatocellular carcinoma (HCC) is a type of liver cancer that can be caused by a variety of factors, including chronic hepatitis B and C, cirrhosis, and alcohol abuse. Treatment options for HCC depend on the stage and severity of the cancer. One of the most common options for HCC is drug therapy, which can be used to slow the growth of cancer cells, stop the spread of cancer, or shrink tumors. There are several FDA-approved drugs for the treatment of Hepatocellular Carcinoma Drugs . Sorafenib is one of the most commonly used drugs, and it works by blocking the growth of blood vessels that feed the tumor. Lenvatinib, regorafenib, and cabozantinib are other targeted therapies that can be used to treat HCC.

Immunotherapy Hepatocellular Carcinoma Drugs, such as nivolumab and pembrolizumab, have also been approved for the treatment of HCC. These drugs work by helping the immune system recognize and attack cancer cells. Drug therapy for HCC can have side effects, including fatigue, nausea, and skin rash. It is important for patients to discuss potential side effects and any other concerns with their healthcare provider.